Medicaid Managed CareApril 22, 2024
Medical Policies and Clinical Utilization Management Guidelines update
This article was updated on April 24, 2024.
The Medical Policies, Clinical Utilization Management (UM) Guidelines, and Third-Party Criteria below were developed and/or revised to support clinical coding edits. Note — Several policies and guidelines were revised to provide clarification only and are not included. Existing precertification requirements have not changed.
Please share this notice with other providers in your practice and office staff.
To view a guideline, visit https://providers.anthem.com/ohio-provider/resources/manuals-and-guides
Notes/updates
Updates marked with an asterisk (*) notate that the criteria may be perceived as more restrictive.
- DME.00011 - Electrical Stimulation as a Treatment for Pain and Other Conditions: Surface and Percutaneous Devices:
- Reformatted bullet points to letters
- Added lines to Investigational and Not Medically Necessary statement on electrical stimulation wound treatment device, electromagnetic wound treatment devices and pulsed electromagnetic field stimulation
- LAB.00011 - Selected Protein Biomarker Algorithmic Assays:
- Reformatted bullet points to letters
- Added IMMray® PanCan-d test to the Investigational and Not Medically Necessary statement
- CG-MED-95 - Transanal Irrigation:
- Outlines the Medically Necessary and Not Medically Necessary criteria for transanal irrigation
Medical Policies
On August 10, 2023, the Medical Policy and Technology Assessment Committee (MPTAC) approved the following Medical Policies applicable to Anthem. These medical policies take effect May 23, 2024.
Publish date | Medical Policy number | Medical Policy title | New or revised |
9/27/2023 | *DME.00011 | Electrical Stimulation as a Treatment for Pain and Other Conditions: Surface and Percutaneous Devices | Revised |
9/27/2023 | *LAB.00011 | Selected Protein Biomarker Algorithmic Assays | Revised |
9/27/2023 | SURG.00052 | Percutaneous Vertebral Disc and Vertebral Endplate Procedures | Revised |
Clinical UM Guidelines
On August 10, 2023, the MPTAC approved the following Clinical UM Guidelines applicable to Anthem. These guidelines were adopted by the medical operations committee for Medicaid members on September 28, 2023. These guidelines take effect May 23, 2024.
Publish date | Clinical UM Guideline number | Clinical UM Guideline title | New or revised |
9/27/2023 | *CG-MED-95 | Transanal Irrigation | New |
9/27/2023 | CG-SURG-79 | Implantable Infusion Pumps | Revised |
Anthem Blue Cross and Blue Shield Medicaid is the trade name of Community Insurance Company. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.
OHBCBS-CD-053622-24
PUBLICATIONS: May 2024 Provider Newsletter
To view this article online:
Or scan this QR code with your phone